GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aibotics Inc (OTCPK:AIBT) » Definitions » Research & Development

AIBT (Aibotics) Research & Development : $0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Aibotics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aibotics's Research & Development for the three months ended in Sep. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

Aibotics Research & Development Historical Data

The historical data trend for Aibotics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aibotics Research & Development Chart

Aibotics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - - - -

Aibotics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aibotics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aibotics  (OTCPK:AIBT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aibotics Research & Development Related Terms

Thank you for viewing the detailed overview of Aibotics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Aibotics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aibotics Inc (OTCPK:AIBT) » Definitions » Research & Development
Comparable Companies
CYTOF GSTC CNBX RMTG NEXI PPCBD BTAX ENDV XSNX EVFM VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
100 SE 2nd Street, Suite 2000, Miami, FL, USA, 33131
Website
https://www.aibotics.ai
Aibotics Inc is a holding company specializing in artificial intelligence and robotics. The company focuses on developing, investing in, and managing a diverse portfolio of companies and technologies in industries.
Executives
Mark D. Williams director, 10 percent owner, officer: President, CEO & CFO 480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin director, 10 percent owner, officer: Vice President 480 22ND STREET, BOX 2, HEYBURN ID 83336